Skip to main content

Centessa Pharmaceuticals plc

CNTADelisted Jun 24, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001847903

Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.

13F holders, Q1 2025

Institutional positions in Centessa Pharmaceuticals plc as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
130
+17 vs. Q4 2024
Shares held
124.9M
+498.0K (+0.4%) vs. Q4 2024
Total value
$1.80B
−$286.4M (−13.7%) vs. Q4 2024
New holders
32
42 more added
Sold out
15
38 more reduced

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CNTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 130 institutions
Q1 2021: 0 institutionsQ2 2021: 50 institutionsQ3 2021: 40 institutionsQ4 2021: 47 institutionsQ1 2022: 44 institutionsQ2 2022: 41 institutionsQ3 2022: 44 institutionsQ4 2022: 44 institutionsQ1 2023: 44 institutionsQ2 2023: 45 institutionsQ3 2023: 49 institutionsQ4 2023: 58 institutionsQ1 2024: 69 institutionsQ2 2024: 80 institutionsQ3 2024: 103 institutionsQ4 2024: 114 institutionsQ1 2025: 130 institutionsQ2 2025: 117 institutionsQ3 2025: 125 institutionsQ4 2025: 147 institutionsQ1 2026: 161 institutionsQ2 2026: 0 institutions
Value heldQ1 2025: $1.80B
Q1 2021: $0Q2 2021: $1.05BQ3 2021: $947.5MQ4 2021: $807.8MQ1 2022: $669.1MQ2 2022: $350.3MQ3 2022: $288.7MQ4 2022: $194.4MQ1 2023: $257.5MQ2 2023: $435.4MQ3 2023: $469.6MQ4 2023: $567.4MQ1 2024: $840.7MQ2 2024: $781.2MQ3 2024: $1.74BQ4 2024: $2.08BQ1 2025: $1.80BQ2 2025: $1.62BQ3 2025: $3.11BQ4 2025: $3.60BQ1 2026: $5.90BQ2 2026: $0
Institutions holding CNTA and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 2026161$5.90B
Q4 2025147$3.60B
Q3 2025125$3.11B
Q2 2025117$1.62B
Q1 2025130$1.80B
Q4 2024114$2.08B
Q3 2024103$1.74B
Q2 202480$781.2M
Q1 202469$840.7M
Q4 202358$567.4M
Q3 202349$469.6M
Q2 202345$435.4M
Q1 202344$257.5M
Q4 202244$194.4M
Q3 202244$288.7M
Q2 202241$350.3M
Q1 202244$669.1M
Q4 202147$807.8M
Q3 202140$947.5M
Q2 202150$1.05B
Q1 20210$0

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Centessa Pharmaceuticals plc; share changes are against Q4 2024.

Institutions holding CNTA in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Tanager Wealth Management LLP696,096$10.0M1.30%00.0%Unchanged
Citadel Advisors LLC706,331$10.2M0.01%+81,015+13.0%Added
5AM Venture Management, LLC830,945$11.9M4.52%00.0%Unchanged
Susquehanna International Group, LLP899,505$12.9M0.02%+883,759+5,612.6%Added
American Century Companies Inc1,092,754$15.7M0.01%+13,046+1.2%Added
Driehaus Capital Management LLC1,095,533$15.8M0.15%−502,650−31.5%Reduced
Baker Bros. Advisors LP1,227,178$17.6M0.20%00.0%Unchanged
Foresite Capital Management VI LLC1,253,379$18.0M9.87%00.0%Unchanged
Octagon Capital Advisors LP1,425,000$20.5M4.45%−568,052−28.5%Reduced
Affinity Asset Advisors, LLC1,546,662$22.2M3.48%+450,738+41.1%Added
T. Rowe Price Investment Management, Inc.1,753,248$25.2M0.02%−1,665,352−48.7%Reduced
Holocene Advisors, LP2,255,679$32.4M0.10%+2,255,679New
Cormorant Asset Management, LP2,261,600$32.5M2.46%−300,000−11.7%Reduced
Point72 Asset Management, L.P.2,286,433$32.9M0.09%−1,140,166−33.3%Reduced
Commodore Capital LP2,367,578$34.0M2.51%+149,153+6.7%Added
Franklin Resources Inc2,541,999$36.6M0.01%+233,453+10.1%Added
TCG Crossover Management, LLC2,890,816$41.6M5.67%00.0%Unchanged
Morgan Stanley2,937,467$42.2M0.00%+1,012,958+52.6%Added
Siren, L.L.C.2,960,029$42.6M2.40%−44,648−1.5%Reduced
Perceptive Advisors LLC3,040,395$43.7M1.55%−3,308,825−52.1%Reduced
FMR LLC3,826,194$55.0M0.00%+174,600+4.8%Added
Avoro Capital Advisors LLC4,050,000$58.2M0.91%+4,050,000New
Farallon Capital Management, L.L.C.4,334,318$62.3M0.34%+835,609+23.9%Added
First Light Asset Management, LLC4,874,124$70.1M8.00%−931,060−16.0%Reduced
Price T Rowe Associates Inc5,342,344$76.8M0.01%−22,048−0.4%Reduced
Janus Henderson Group PLC5,922,486$86.4M0.05%+1,012,999+20.6%Added
Adage Capital Partners GP, L.L.C.6,954,000$100.0M0.19%+1,834,973+35.8%Added
General Atlantic LLC9,681,818$139.2M4.67%00.0%Unchanged
Index Venture Life Associates VI Ltd9,961,789$143.3M100.00%00.0%Unchanged
Medicxi Ventures Management (Jersey) Ltd19,963,157$287.1M65.59%00.0%Unchanged
Vida Ventures Advisors, LLC0$00.00%−3,931,818−100.0%Sold out
Deep Track Capital, LP0$00.00%−1,350,000−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−175,428−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−71,947−100.0%Sold out
DAFNA Capital Management LLC0$00.00%−47,453−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−45,885−100.0%Sold out
Jump Financial, LLC0$00.00%−25,700−100.0%Sold out
Jain Global LLC0$00.00%−23,466−100.0%Sold out
Lynx1 Capital Management LP0$00.00%−17,400−100.0%Sold out
Atom Investors LP0$00.00%−17,197−100.0%Sold out
Omers Administration Corp0$00.00%−10,200−100.0%Sold out
Virtus ETF Advisers LLC0$00.00%−4,214−100.0%Sold out
Advisors Preferred, LLC0$00.00%−2,372−100.0%Sold out
Acadian Asset Management LLC0$00.00%−1,457−100.0%Sold out
R Squared Ltd0$00.00%−990−100.0%Sold out
Global Retirement Partners, LLC––––Not filed